Related Experiment Videos
Bcl-x gene expression in Hodgkin's disease
D Schlaifer1, S Krajewski, F Rigal-Huguet
1Service d'Hématologie, Clinique Dieulafoy, Centre Hospitalier Universitaire, Hôpital de Purpan, Toulouse, France.
Leukemia & Lymphoma
|September 1, 1996
Summary
Bcl-x protein is highly detected in Hodgkin
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Bcl-x is a Bcl-2-family protein found in immune cells.
- Its role in apoptosis and drug resistance is complex.
- Bcl-2 family proteins regulate cell death pathways.
Purpose of the Study:
- To investigate the detection rate of Bcl-x in Hodgkin's disease.
- To understand the significance of Bcl-x in the Bcl-2 protein family.
- To explore the therapeutic potential of targeting Bcl-x in Hodgkin's disease.
Main Methods:
- Detection rate analysis of Bcl-x protein in Hodgkin's disease samples.
- Investigation of Bcl-x heterodimerization with Bcl-2 and Bax.
- In vitro studies on Bcl-x and drug resistance.
Main Results:
- Bcl-x protein was detected in 86% of Hodgkin's disease samples.
- Bcl-x heterodimerizes with both anti-apoptotic Bcl-2 and pro-apoptotic Bax.
- Evidence suggests Bcl-x may induce multidrug resistance in vitro.
Conclusions:
- High Bcl-x detection in Hodgkin's disease suggests a significant role.
- The complex interactions of Bcl-x within the Bcl-2 family are crucial.
- Targeting Bcl-x may offer therapeutic strategies for Hodgkin's disease.